APA (7th ed.) Citation

Owen, D. R., Allerton, C. M. N., Anderson, A. S., Aschenbrenner, L., Avery, M., Berritt, S., . . . Zhu, Y. (2021). An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19. Science (American Association for the Advancement of Science), 374(6575), 1586. https://doi.org/10.1126/science.abl4784

Chicago Style (17th ed.) Citation

Owen, Dafydd R., et al. "An Oral SARS-CoV-2 Mpro Inhibitor Clinical Candidate for the Treatment of COVID-19." Science (American Association for the Advancement of Science) 374, no. 6575 (2021): 1586. https://doi.org/10.1126/science.abl4784.

MLA (9th ed.) Citation

Owen, Dafydd R., et al. "An Oral SARS-CoV-2 Mpro Inhibitor Clinical Candidate for the Treatment of COVID-19." Science (American Association for the Advancement of Science), vol. 374, no. 6575, 2021, p. 1586, https://doi.org/10.1126/science.abl4784.